Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Urinary Antispasodics Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 10 mg
1.2.3 20 mg
1.2.4 30 mg
1.2.5 Others
1.3 Market by Application
1.3.1 Global Urinary Antispasodics Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Men
1.3.3 Women
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Urinary Antispasodics Market Perspective (2018-2034)
2.2 Urinary Antispasodics Growth Trends by Region
2.2.1 Global Urinary Antispasodics Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 Urinary Antispasodics Historic Market Size by Region (2018-2023)
2.2.3 Urinary Antispasodics Forecasted Market Size by Region (2024-2034)
2.3 Urinary Antispasodics Market Dynamics
2.3.1 Urinary Antispasodics Industry Trends
2.3.2 Urinary Antispasodics Market Drivers
2.3.3 Urinary Antispasodics Market Challenges
2.3.4 Urinary Antispasodics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Urinary Antispasodics Players by Revenue
3.1.1 Global Top Urinary Antispasodics Players by Revenue (2018-2023)
3.1.2 Global Urinary Antispasodics Revenue Market Share by Players (2018-2023)
3.2 Global Urinary Antispasodics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Urinary Antispasodics Revenue
3.4 Global Urinary Antispasodics Market Concentration Ratio
3.4.1 Global Urinary Antispasodics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Urinary Antispasodics Revenue in 2024
3.5 Urinary Antispasodics Key Players Head office and Area Served
3.6 Key Players Urinary Antispasodics Product Solution and Service
3.7 Date of Enter into Urinary Antispasodics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Urinary Antispasodics Breakdown Data by Type
4.1 Global Urinary Antispasodics Historic Market Size by Type (2018-2023)
4.2 Global Urinary Antispasodics Forecasted Market Size by Type (2024-2034)
5 Urinary Antispasodics Breakdown Data by Application
5.1 Global Urinary Antispasodics Historic Market Size by Application (2018-2023)
5.2 Global Urinary Antispasodics Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Urinary Antispasodics Market Size (2018-2034)
6.2 North America Urinary Antispasodics Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America Urinary Antispasodics Market Size by Country (2018-2023)
6.4 North America Urinary Antispasodics Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Urinary Antispasodics Market Size (2018-2034)
7.2 Europe Urinary Antispasodics Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe Urinary Antispasodics Market Size by Country (2018-2023)
7.4 Europe Urinary Antispasodics Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Urinary Antispasodics Market Size (2018-2034)
8.2 Asia-Pacific Urinary Antispasodics Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific Urinary Antispasodics Market Size by Region (2018-2023)
8.4 Asia-Pacific Urinary Antispasodics Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Urinary Antispasodics Market Size (2018-2034)
9.2 Latin America Urinary Antispasodics Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America Urinary Antispasodics Market Size by Country (2018-2023)
9.4 Latin America Urinary Antispasodics Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Urinary Antispasodics Market Size (2018-2034)
10.2 Middle East & Africa Urinary Antispasodics Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa Urinary Antispasodics Market Size by Country (2018-2023)
10.4 Middle East & Africa Urinary Antispasodics Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Urinary Antispasodics Introduction
11.1.4 Pfizer Revenue in Urinary Antispasodics Business (2018-2023)
11.1.5 Pfizer Recent Development
11.2 Piramal Pharma Solutions
11.2.1 Piramal Pharma Solutions Company Detail
11.2.2 Piramal Pharma Solutions Business Overview
11.2.3 Piramal Pharma Solutions Urinary Antispasodics Introduction
11.2.4 Piramal Pharma Solutions Revenue in Urinary Antispasodics Business (2018-2023)
11.2.5 Piramal Pharma Solutions Recent Development
11.3 Allergan
11.3.1 Allergan Company Detail
11.3.2 Allergan Business Overview
11.3.3 Allergan Urinary Antispasodics Introduction
11.3.4 Allergan Revenue in Urinary Antispasodics Business (2018-2023)
11.3.5 Allergan Recent Development
11.4 Astellas
11.4.1 Astellas Company Detail
11.4.2 Astellas Business Overview
11.4.3 Astellas Urinary Antispasodics Introduction
11.4.4 Astellas Revenue in Urinary Antispasodics Business (2018-2023)
11.4.5 Astellas Recent Development
11.5 Eywa Pharma
11.5.1 Eywa Pharma Company Detail
11.5.2 Eywa Pharma Business Overview
11.5.3 Eywa Pharma Urinary Antispasodics Introduction
11.5.4 Eywa Pharma Revenue in Urinary Antispasodics Business (2018-2023)
11.5.5 Eywa Pharma Recent Development
11.6 Rising Pharmaceuticals
11.6.1 Rising Pharmaceuticals Company Detail
11.6.2 Rising Pharmaceuticals Business Overview
11.6.3 Rising Pharmaceuticals Urinary Antispasodics Introduction
11.6.4 Rising Pharmaceuticals Revenue in Urinary Antispasodics Business (2018-2023)
11.6.5 Rising Pharmaceuticals Recent Development
11.7 Otto Brandes GmbH
11.7.1 Otto Brandes GmbH Company Detail
11.7.2 Otto Brandes GmbH Business Overview
11.7.3 Otto Brandes GmbH Urinary Antispasodics Introduction
11.7.4 Otto Brandes GmbH Revenue in Urinary Antispasodics Business (2018-2023)
11.7.5 Otto Brandes GmbH Recent Development
11.8 Recordati
11.8.1 Recordati Company Detail
11.8.2 Recordati Business Overview
11.8.3 Recordati Urinary Antispasodics Introduction
11.8.4 Recordati Revenue in Urinary Antispasodics Business (2018-2023)
11.8.5 Recordati Recent Development
11.9 Antares Pharma
11.9.1 Antares Pharma Company Detail
11.9.2 Antares Pharma Business Overview
11.9.3 Antares Pharma Urinary Antispasodics Introduction
11.9.4 Antares Pharma Revenue in Urinary Antispasodics Business (2018-2023)
11.9.5 Antares Pharma Recent Development
11.10 Accord Healthcare
11.10.1 Accord Healthcare Company Detail
11.10.2 Accord Healthcare Business Overview
11.10.3 Accord Healthcare Urinary Antispasodics Introduction
11.10.4 Accord Healthcare Revenue in Urinary Antispasodics Business (2018-2023)
11.10.5 Accord Healthcare Recent Development
11.11 Heritage Pharmaceuticals
11.11.1 Heritage Pharmaceuticals Company Detail
11.11.2 Heritage Pharmaceuticals Business Overview
11.11.3 Heritage Pharmaceuticals Urinary Antispasodics Introduction
11.11.4 Heritage Pharmaceuticals Revenue in Urinary Antispasodics Business (2018-2023)
11.11.5 Heritage Pharmaceuticals Recent Development
11.12 Lannett
11.12.1 Lannett Company Detail
11.12.2 Lannett Business Overview
11.12.3 Lannett Urinary Antispasodics Introduction
11.12.4 Lannett Revenue in Urinary Antispasodics Business (2018-2023)
11.12.5 Lannett Recent Development
11.13 Leading Pharma
11.13.1 Leading Pharma Company Detail
11.13.2 Leading Pharma Business Overview
11.13.3 Leading Pharma Urinary Antispasodics Introduction
11.13.4 Leading Pharma Revenue in Urinary Antispasodics Business (2018-2023)
11.13.5 Leading Pharma Recent Development
11.14 Major Pharmaceuticals
11.14.1 Major Pharmaceuticals Company Detail
11.14.2 Major Pharmaceuticals Business Overview
11.14.3 Major Pharmaceuticals Urinary Antispasodics Introduction
11.14.4 Major Pharmaceuticals Revenue in Urinary Antispasodics Business (2018-2023)
11.14.5 Major Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Urinary Antispasodics Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of 10 mg
Table 3. Key Players of 20 mg
Table 4. Key Players of 30 mg
Table 5. Key Players of Others
Table 6. Global Urinary Antispasodics Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 7. Global Urinary Antispasodics Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 8. Global Urinary Antispasodics Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Urinary Antispasodics Market Share by Region (2018-2023)
Table 10. Global Urinary Antispasodics Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 11. Global Urinary Antispasodics Market Share by Region (2024-2034)
Table 12. Urinary Antispasodics Market Trends
Table 13. Urinary Antispasodics Market Drivers
Table 14. Urinary Antispasodics Market Challenges
Table 15. Urinary Antispasodics Market Restraints
Table 16. Global Urinary Antispasodics Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Urinary Antispasodics Market Share by Players (2018-2023)
Table 18. Global Top Urinary Antispasodics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urinary Antispasodics as of 2024)
Table 19. Ranking of Global Top Urinary Antispasodics Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Urinary Antispasodics Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Urinary Antispasodics Product Solution and Service
Table 23. Date of Enter into Urinary Antispasodics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Urinary Antispasodics Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Urinary Antispasodics Revenue Market Share by Type (2018-2023)
Table 27. Global Urinary Antispasodics Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 28. Global Urinary Antispasodics Revenue Market Share by Type (2024-2034)
Table 29. Global Urinary Antispasodics Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Urinary Antispasodics Revenue Market Share by Application (2018-2023)
Table 31. Global Urinary Antispasodics Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 32. Global Urinary Antispasodics Revenue Market Share by Application (2024-2034)
Table 33. North America Urinary Antispasodics Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 34. North America Urinary Antispasodics Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Urinary Antispasodics Market Size by Country (2024-2034) & (US$ Million)
Table 36. Europe Urinary Antispasodics Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 37. Europe Urinary Antispasodics Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Urinary Antispasodics Market Size by Country (2024-2034) & (US$ Million)
Table 39. Asia-Pacific Urinary Antispasodics Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 40. Asia-Pacific Urinary Antispasodics Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Urinary Antispasodics Market Size by Region (2024-2034) & (US$ Million)
Table 42. Latin America Urinary Antispasodics Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 43. Latin America Urinary Antispasodics Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Urinary Antispasodics Market Size by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Urinary Antispasodics Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 46. Middle East & Africa Urinary Antispasodics Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Urinary Antispasodics Market Size by Country (2024-2034) & (US$ Million)
Table 48. Pfizer Company Detail
Table 49. Pfizer Business Overview
Table 50. Pfizer Urinary Antispasodics Product
Table 51. Pfizer Revenue in Urinary Antispasodics Business (2018-2023) & (US$ Million)
Table 52. Pfizer Recent Development
Table 53. Piramal Pharma Solutions Company Detail
Table 54. Piramal Pharma Solutions Business Overview
Table 55. Piramal Pharma Solutions Urinary Antispasodics Product
Table 56. Piramal Pharma Solutions Revenue in Urinary Antispasodics Business (2018-2023) & (US$ Million)
Table 57. Piramal Pharma Solutions Recent Development
Table 58. Allergan Company Detail
Table 59. Allergan Business Overview
Table 60. Allergan Urinary Antispasodics Product
Table 61. Allergan Revenue in Urinary Antispasodics Business (2018-2023) & (US$ Million)
Table 62. Allergan Recent Development
Table 63. Astellas Company Detail
Table 64. Astellas Business Overview
Table 65. Astellas Urinary Antispasodics Product
Table 66. Astellas Revenue in Urinary Antispasodics Business (2018-2023) & (US$ Million)
Table 67. Astellas Recent Development
Table 68. Eywa Pharma Company Detail
Table 69. Eywa Pharma Business Overview
Table 70. Eywa Pharma Urinary Antispasodics Product
Table 71. Eywa Pharma Revenue in Urinary Antispasodics Business (2018-2023) & (US$ Million)
Table 72. Eywa Pharma Recent Development
Table 73. Rising Pharmaceuticals Company Detail
Table 74. Rising Pharmaceuticals Business Overview
Table 75. Rising Pharmaceuticals Urinary Antispasodics Product
Table 76. Rising Pharmaceuticals Revenue in Urinary Antispasodics Business (2018-2023) & (US$ Million)
Table 77. Rising Pharmaceuticals Recent Development
Table 78. Otto Brandes GmbH Company Detail
Table 79. Otto Brandes GmbH Business Overview
Table 80. Otto Brandes GmbH Urinary Antispasodics Product
Table 81. Otto Brandes GmbH Revenue in Urinary Antispasodics Business (2018-2023) & (US$ Million)
Table 82. Otto Brandes GmbH Recent Development
Table 83. Recordati Company Detail
Table 84. Recordati Business Overview
Table 85. Recordati Urinary Antispasodics Product
Table 86. Recordati Revenue in Urinary Antispasodics Business (2018-2023) & (US$ Million)
Table 87. Recordati Recent Development
Table 88. Antares Pharma Company Detail
Table 89. Antares Pharma Business Overview
Table 90. Antares Pharma Urinary Antispasodics Product
Table 91. Antares Pharma Revenue in Urinary Antispasodics Business (2018-2023) & (US$ Million)
Table 92. Antares Pharma Recent Development
Table 93. Accord Healthcare Company Detail
Table 94. Accord Healthcare Business Overview
Table 95. Accord Healthcare Urinary Antispasodics Product
Table 96. Accord Healthcare Revenue in Urinary Antispasodics Business (2018-2023) & (US$ Million)
Table 97. Accord Healthcare Recent Development
Table 98. Heritage Pharmaceuticals Company Detail
Table 99. Heritage Pharmaceuticals Business Overview
Table 100. Heritage Pharmaceuticals Urinary Antispasodics Product
Table 101. Heritage Pharmaceuticals Revenue in Urinary Antispasodics Business (2018-2023) & (US$ Million)
Table 102. Heritage Pharmaceuticals Recent Development
Table 103. Lannett Company Detail
Table 104. Lannett Business Overview
Table 105. Lannett Urinary Antispasodics Product
Table 106. Lannett Revenue in Urinary Antispasodics Business (2018-2023) & (US$ Million)
Table 107. Lannett Recent Development
Table 108. Leading Pharma Company Detail
Table 109. Leading Pharma Business Overview
Table 110. Leading Pharma Urinary Antispasodics Product
Table 111. Leading Pharma Revenue in Urinary Antispasodics Business (2018-2023) & (US$ Million)
Table 112. Leading Pharma Recent Development
Table 113. Major Pharmaceuticals Company Detail
Table 114. Major Pharmaceuticals Business Overview
Table 115. Major Pharmaceuticals Urinary Antispasodics Product
Table 116. Major Pharmaceuticals Revenue in Urinary Antispasodics Business (2018-2023) & (US$ Million)
Table 117. Major Pharmaceuticals Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Urinary Antispasodics Market Size Comparison by Type (2023-2034) & (US$ Million)
Figure 2. Global Urinary Antispasodics Market Share by Type: 2024 VS 2034
Figure 3. 10 mg Features
Figure 4. 20 mg Features
Figure 5. 30 mg Features
Figure 6. Others Features
Figure 7. Global Urinary Antispasodics Market Size Comparison by Application (2023-2034) & (US$ Million)
Figure 8. Global Urinary Antispasodics Market Share by Application: 2024 VS 2034
Figure 9. Men Case Studies
Figure 10. Women Case Studies
Figure 11. Urinary Antispasodics Report Years Considered
Figure 12. Global Urinary Antispasodics Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 13. Global Urinary Antispasodics Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 14. Global Urinary Antispasodics Market Share by Region: 2024 VS 2034
Figure 15. Global Urinary Antispasodics Market Share by Players in 2024
Figure 16. Global Top Urinary Antispasodics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urinary Antispasodics as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Urinary Antispasodics Revenue in 2024
Figure 18. North America Urinary Antispasodics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 19. North America Urinary Antispasodics Market Share by Country (2018-2034)
Figure 20. United States Urinary Antispasodics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 21. Canada Urinary Antispasodics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 22. Europe Urinary Antispasodics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. Europe Urinary Antispasodics Market Share by Country (2018-2034)
Figure 24. Germany Urinary Antispasodics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. France Urinary Antispasodics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. U.K. Urinary Antispasodics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. Italy Urinary Antispasodics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. Russia Urinary Antispasodics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Nordic Countries Urinary Antispasodics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Asia-Pacific Urinary Antispasodics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Asia-Pacific Urinary Antispasodics Market Share by Region (2018-2034)
Figure 32. China Urinary Antispasodics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Japan Urinary Antispasodics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. South Korea Urinary Antispasodics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. Southeast Asia Urinary Antispasodics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. India Urinary Antispasodics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. Australia Urinary Antispasodics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. Latin America Urinary Antispasodics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. Latin America Urinary Antispasodics Market Share by Country (2018-2034)
Figure 40. Mexico Urinary Antispasodics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. Brazil Urinary Antispasodics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Middle East & Africa Urinary Antispasodics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Middle East & Africa Urinary Antispasodics Market Share by Country (2018-2034)
Figure 44. Turkey Urinary Antispasodics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Saudi Arabia Urinary Antispasodics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. Pfizer Revenue Growth Rate in Urinary Antispasodics Business (2018-2023)
Figure 47. Piramal Pharma Solutions Revenue Growth Rate in Urinary Antispasodics Business (2018-2023)
Figure 48. Allergan Revenue Growth Rate in Urinary Antispasodics Business (2018-2023)
Figure 49. Astellas Revenue Growth Rate in Urinary Antispasodics Business (2018-2023)
Figure 50. Eywa Pharma Revenue Growth Rate in Urinary Antispasodics Business (2018-2023)
Figure 51. Rising Pharmaceuticals Revenue Growth Rate in Urinary Antispasodics Business (2018-2023)
Figure 52. Otto Brandes GmbH Revenue Growth Rate in Urinary Antispasodics Business (2018-2023)
Figure 53. Recordati Revenue Growth Rate in Urinary Antispasodics Business (2018-2023)
Figure 54. Antares Pharma Revenue Growth Rate in Urinary Antispasodics Business (2018-2023)
Figure 55. Accord Healthcare Revenue Growth Rate in Urinary Antispasodics Business (2018-2023)
Figure 56. Heritage Pharmaceuticals Revenue Growth Rate in Urinary Antispasodics Business (2018-2023)
Figure 57. Lannett Revenue Growth Rate in Urinary Antispasodics Business (2018-2023)
Figure 58. Leading Pharma Revenue Growth Rate in Urinary Antispasodics Business (2018-2023)
Figure 59. Major Pharmaceuticals Revenue Growth Rate in Urinary Antispasodics Business (2018-2023)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed